Two-year Clinical Outcomes Following Everolimus-eluting Stent Use for Off-label Versus On-label Indications: From the Korean Multicenter Drug-eluting Stent Registry.

Jong Yop Pae, Kwon Bae Kim, Ji Yong Choi et al.|Unknown|2018

Cited by 0